Benefit of giving estrogen in IVF cycles.

Not Applicable

Completed

• Conditions: Health Condition 1: null- Infertile patients undergoing IVF

• Registration Number: CTRI/2017/10/010083
• Lead Sponsor: Maulana Azad Medical College and Lok Nayak Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2013-02-11
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

Women receiving long protocol of down regulation with GnRH agonist and controlled ovarian stimulation with gonadotropins.

Exclusion Criteria

Serum E2 >3000pg/ml on day of oocyte retrieval, Diminished ovarian reserve( Day2 serum FSH >10mIU/ml), Endometriosis greater than stage2, Severe male factor(less than 5million/ml motile spermatozoa), Endocrine disorders, Medical or surgical illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy rate in two groupsTimepoint: After 14days of Embryo transfer.

Secondary Outcome Measures

Name	Time	Method
Serum levels of Ethinyl Estradiol and Progesterone.Timepoint: On the day of oocyte retrieval, day of embryo transfer, three days after embryo transfer and on day day of results, ie, 14days after embryo transfer.